Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. - Wikidata - awgldk - TriplyDB

Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.

Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.

http://www.wikidata.org/entity/Q40030460

about

Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27(Kip1) ubiquitination pathway in hepatocellular carcinoma MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein Surgical approach for hepatitis C virus-related hepatocellular carcinoma The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review)The histone deacetylase inhibitor, Vorinostat, represses hypoxia inducible factor 1 alpha expression through translational inhibition N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q.A meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular carcinoma.Structural models of human eEF1A1 and eEF1A2 reveal two distinct surface clusters of sequence variation and potential differences in phosphorylation.c-MYC-Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease.miR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinoma MYC Deregulation in Primary Human Cancers.Identification of drivers from cancer genome diversity in hepatocellular carcinoma.EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma.Postnatal liver growth and regeneration are independent of c-myc in a mouse model of conditional hepatic c-myc deletion Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.Targeting c-Myc as a novel approach for hepatocellular carcinoma.Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients.Cirrhosis and Chronic Viral Hepatitis as Risk Factors for Hepatocellular Carcinoma: Romanian Single-clinic Experience.In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer.Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma.CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background.Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment.MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors Monocytes promote liver carcinogenesis in an oncogene-specific manner.Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?FOXR2 Interacts with MYC to Promote Its Transcriptional Activities and Tumorigenesis.Enhanced angiogenesis, hypoxia and neutrophil recruitment during Myc-induced liver tumorigenesis in zebrafish Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.Identification of genomic functional hotspots with copy number alteration in liver cancer MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer.Accomplishments in 2008 in the management of hepatobiliary cancers.Proliferation inhibition and the underlying molecular mechanisms of microRNA-30d in renal carcinoma cells.Strategies for hepatocellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches.Molecular characteristics of non-cancerous liver tissue in non-B non-C hepatocellular carcinoma.From global phosphoproteomics to individual proteins: the case of translation elongation factor eEF1A.

P2860

Q24298070-A02BA5BD-1187-4471-8033-D924EE69A78F Q24601263-B17B3E1A-96DF-474C-919E-70ECF4A7690D Q26824046-F523EBDF-86A1-4727-9B7A-B8180A392C64 Q26825635-140C211E-2D0E-4811-96D6-0873EE3DEE0E Q28383106-908B5B4C-69E7-4D2D-BB99-519132ED1976 Q28394917-23099FD0-A7AA-476E-82F7-3D639F7C4518 Q28542639-F180CA82-9AA8-406D-B5F6-21E314C5AED8 Q28771715-DE5929E5-0396-46BE-8131-E5E5E06D3EEC Q30488297-429DA740-913F-4EC1-83E8-6B4CD53EC94E Q31043530-C33F351E-67F1-4BE5-870E-5A0ADC36F9D3 Q33487694-3301DFD9-C9E8-444E-8F5F-C34383818CE4 Q33608524-C6CABF17-A1F4-46CD-8A18-488547E717A7 Q33661028-D8CE7FFB-320F-487F-8860-69AC4C4B8689 Q33836755-CB731210-9E5D-4B08-8E8B-A033C3EB84ED Q33907993-32A60E51-3A87-4BA3-B1E6-EFD05AA6D328 Q33970628-981C9F40-8C64-46CD-96EB-205922046B92 Q34187598-9D2E056E-2FBF-4E95-8858-281BE57FF37C Q34376920-A415D111-72B9-4220-8AB8-E96241606922 Q34391522-9BB0E0D3-4DA2-4F97-9493-5C24ACCD8A70 Q34993975-69A05F22-475D-4486-BF16-9F324A84CD92 Q35154758-DDCCDAE8-A0CC-45B3-9817-592B4139D96D Q35250612-AC1C642F-88D3-4D56-9D1C-DC38F7533918 Q35338422-E496F2F1-A460-49DF-8244-3E5D39D45C28 Q35741547-2C8EB886-5B55-40E1-8B63-5A9B700C6C39 Q35907583-4B6DCD33-4900-4050-AB2A-E17813B5222C Q36165673-FCA575DD-2868-45C7-BD68-4CCC72B8998E Q36380197-86B60F77-4950-40BF-94BD-7132E7C80AF9 Q36706259-3FE0F35A-3FF9-47EB-B40B-77D8EB853362 Q36815029-DFFEA222-BA8E-4F56-B891-E865C25CF455 Q37068706-2466FF75-D57E-47EB-A5FD-4397D4399926 Q37097265-06BC734E-AEF4-40D4-A13C-AD7A44E81963 Q37195560-480208D3-C142-4877-8F1F-BEDC4A20D482 Q37295260-2109B70D-54E8-481B-98E5-A73BC243D554 Q37323311-A29A3F7A-84C3-48C1-A504-CA28BDB19762 Q37423734-91169D5B-16C3-49CF-876E-59EE4CAA6B7F Q37468851-FBE31474-3EFD-4C36-80FC-57559E1BAFE9 Q37575126-205D016B-4320-4C2C-98EC-26D9C5E582EC Q37857056-D87BBFD6-0559-4683-A902-FCABEBA2DEF3 Q37891167-C614E900-4D19-4692-A0B1-211D10FDC1C7 Q37980245-DF11806B-7F02-43EE-A28C-DB9A24D5B4C9

P2860

Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.

http://www.wikidata.org/entity/Q40030460

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.

@en

type

label

Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.

@en

prefLabel

Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.

@en

P1433

Q40030460-A8997E71-69E5-46E7-8D12-37AFFA06F89C

P1476

Q40030460-9C0F2F56-D80A-4BDE-B3EB-CCA464609D77

P2093

Q40030460-0DFDD6D5-5BFD-4E29-B2D0-5CCA9B731995

Q40030460-1004489F-6F61-4D85-AE61-56A099172CA4

Q40030460-25EFAC6E-8A0F-4614-99D0-0D07D861FCED

Q40030460-4DEC5D6C-95A8-4534-A74E-FA017680BF62

Q40030460-575A71E6-625B-4840-880A-0DAC8FA71319

Q40030460-795AC026-C614-45A2-88E4-075BFF0E8EB9

Q40030460-D2ECED68-5C59-4063-ADFB-6F6D27C08E4A

Q40030460-DB64D702-92FE-4E4E-9C37-BB290661D41A

P304

Q40030460-1FDDB4C0-2480-4585-A614-CDBADE0BA3CA

P31

Q40030460-423462CB-4A0A-4A95-BFB8-C338BC97E008

P356

Q40030460-33B433FF-F236-404D-B7E2-22D44AE8770F

P407

Q40030460-97B0F0ED-2909-44B2-A08D-168287FE8AC7

P433

Q40030460-F1B9B348-B97C-432F-9F27-D159365920C3

P478

Q40030460-85263C98-1024-4891-A535-4CAD3A63D599

P50

Q40030460-2EB74274-BAC2-4628-9A29-4571E80BF059

Q40030460-5C2EA2BE-11EC-4A76-8B1E-0FC157156E1A

Q40030460-8195167C-3CD7-476F-9930-63A575D88167

Q40030460-D99EE436-A2F2-4AC1-8B7C-CE826D578653

P577

Q40030460-C496A71A-18C0-4F13-9D2D-DF5D2532E71F

P5875

Q40030460-919EBFFB-EBFE-4350-8888-21E7B515749C

P698

Q40030460-EB337ACF-C90D-4FA9-901F-55B915E49249

P356

P1433

P1476

Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.

@en

P2093

Christof Schlaeger

http://www.w3.org/2001/XMLSchema#string

Claudia Schiller

http://www.w3.org/2001/XMLSchema#string

Grischa Toedt

http://www.w3.org/2001/XMLSchema#string

Jörg Kleeff

http://www.w3.org/2001/XMLSchema#string

Peter Bewerunge

http://www.w3.org/2001/XMLSchema#string

Peter Schirmacher

http://www.w3.org/2001/XMLSchema#string

Thomas Longerich

http://www.w3.org/2001/XMLSchema#string

Volker Ehemann

http://www.w3.org/2001/XMLSchema#string

P304

511-520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.22033

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Bernhard Radlwimmer

Arianeb Mehrabi

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5688479

http://www.w3.org/2001/XMLSchema#string

P698

18161050

http://www.w3.org/2001/XMLSchema#string